Lv31
230 积分 2023-06-01 加入
APOBEC3 upregulation drives gemcitabine resistance
6小时前
待确认
Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment
1个月前
已完结
Arabidopsis Pentatricopeptide Repeat Protein GEND2 Participates in Mitochondrial RNA Editing
1个月前
已完结
Targeting of drug-tolerant persister cells as an approach to counter drug resistance in non-small cell lung cancer
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
Mechanisms of Resistance to CDK4/6 Inhibitors in Hormone Receptor-Positive (HR +) Breast Cancer: Spotlight on Convergent CDK6 Upregulation and Immune Signaling
5个月前
已完结
Targeting APOBECs in cancer: It’s about timing
5个月前
已完结
APOBEC3 upregulation drives gemcitabine resistance
5个月前
已完结
APOBEC3A drives acquired resistance to targeted therapies in non small cell lung cancer
5个月前
已关闭
APOBEC3A drives resistance
5个月前
已完结
H 2 ‐Directing Strategy on In Situ Synthesis of Co‐MoS 2 with Highly Expanded Interlayer for Elegant HER Activity and its Mechanism
皖公网安备34019202002308
